Cholera toxin triggers apoptosis in human lung cancer cell lines

Cancer Research

Volumn 57, Issue 13, 1997, Pages 2615-2618

  Allam, Mustapha ^a   Bertrand, Richard ^a   Zhang Sun, Guiyi ^a   Pappas, Jane ^a   Viallet, Jean ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Sanofi Research Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELERYTHRINE; CHOLERA TOXIN; CYCLIC AMP; DNA FRAGMENT; GROWTH FACTOR; ISOBUTYLMETHYLXANTHINE; LAMIN B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE C; SERINE PROTEINASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DNA DEGRADATION; GROWTH REGULATION; HUMAN; HUMAN CELL; LUNG CARCINOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL;

1-METHYL-3-ISOBUTYLXANTHINE; ALKALOIDS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZOPHENANTHRIDINES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CHOLERA TOXIN; CYCLIC AMP; DNA FRAGMENTATION; ENZYME INHIBITORS; HUMANS; LUNG NEOPLASMS; PHENANTHRIDINES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0030744379     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cuttitta, F., Carney, D. N., Muishine, J., Moody, T. W., Federko, J., Fischler, A., and Minna, J. D. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer. Nature (Lond.), 316: 823-826, 1985.
2. Sethi, T., and Rozengurt, E. Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effect of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin. Cancer Res., 51: 3621-3623, 1991.
3. Viallet, J., Sharoni, Y., Frucht, H., Jensen, R. T., Minna, J. D., and Sausville, E. A. Cholera toxin inhibits signal transduction by several mitogens and the in vitro growth of small cell lung cancer. J. Clin. Invest., 86: 1904-1912, 1990.
4. M1 ganglioside expression. Cancer Res., 52: 3340-3346, 1992.
5. Viallet, J., and Sausville, E. A. Involvement of signal transduction pathways in lung cancer biology. J. Cell. Biochem., 24 (Suppl.): 228-236, 1996.
6. Baserga, R. Oncogenes and the strategy of growth factors (Review). Cell, 79: 927-930, 1994.
7. Bertrand, R., Sarang, M., Jenkin, J., Kerrigan, D., and Pommier, Y. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res., 51: 6280-6285, 1991.
8. Ellis, C., Moran, M., McCormick, F., and Pawson, T. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature (Lond.), 343: 377-381, 1990.
9. Kerr, J. F., Wyllie, A. H., and Currie, A. R., Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
10. Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.), 284: 555-556, 1980.
11. Kumar, S., and Harvey, N. L. Role of multiple cellular proteases in the execution of programmed cell death (Review). FEBS Lett., 375: 169-173, 1995.
12. Patel, T., Gores, G. J., and Kaufmann, S. H. The role of proteases during apoptosis (Review). FASEB J., 10: 587-597, 1996.
13. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thomberry, N. A., Wong, W. W., and Yuan, J. Human ICE/CED-3 protease nomenclature. Cell, 87: 171, 1996.
14. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994.
15. Neamati, N., Fernandez, A., Wright, S., Kiefer, J., and McConkey, D. J., Degradation of lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei. J. Immunol., 154: 3788-3795, 1995.
16. Treppel, J. B., Moyer, J. D., Heikkila, R., and Sausville, E. S., Modulation of bombesin-induced phosphatidylinositol hydrolysis in a small cell king cancel cell line. Biochem. J., 255: 403-410, 1988.
17. Yang, E., and Korsmeyer, S. J. Molecular thanatopsis: a discourse on the Bcl2 family and cell death (Review). Blood, 88: 386-401, 1996.
18. Chresta, C. M., Masters, J. R. W., and Hickman, J. A. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res., 56: 1834-1841, 1996.
19. Thomas, A., Elrouby, S., Reed, J. C. Krajewski, S., Silber, R., Potmesil, M. and Newcomb, E. W. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and Bcl-2/Bax proteins in drug resistance. Oncogene, 12: 1055-1062, 1996.
20. McConkey, D. J., Chandra, J., Wright, S., Plunkett, W., McDonnell, T. J., Reed, J. C., and Keating, M. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of Bcl-2 and Bax. J. Immunol., 156: 2624-2630, 1996.
21. Tallett, A., Chilvers, K. R., Hannah, S., Dransfield, I., Lawson, M. F., Haslett, M. F., and Sethi, T. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells. Cancer Res., 56: 4255-4263, 1996.
22. Sell, C., Baserga, R., and Rubin, R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995.